Large-scale testing (Phase 3)Study completedNCT03480763
What this trial is testing
Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Healthy Adults 50 Years of Age or Older (V114-016/PNEU-PATH)
Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 652